Neal Shore

69PUBLICATIONS

253CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapyMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (69)

Sort by Publication Date:

|Jul 09, 2026

Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

|Jun 25, 2026

Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.

|Jun 20, 2026

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

|Jun 02, 2026

Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.

|Jun 01, 2026

Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

|May 11, 2026

Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

Pageof 12

Frequent Collaborators

6 joint publications

Fred Saad

5 joint publications

Emmanuel S Antonarakis

Alicia K Morgans

Rana R McKay

Neeraj Agarwal

Félix Guerrero-Ramos

Edward D Esplin

Alan H Bryce

Lawrence Ivan Karsh

Arun Azad

Frequent Collaborators

6 joint publications

Fred Saad

5 joint publications

Emmanuel S Antonarakis

5 joint publications

Alicia K Morgans

5 joint publications

Rana R McKay